Article Details

Gilead Sciences Raises FY Guidance Due To Remdesivir Sales

Retrieved on: 2021-01-11 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Gilead Sciences Raises FY Guidance Due To Remdesivir Sales. View article details on hiswai:

Excerpt

You raised your guidance for the full year now because of your Remdesivir sales looking at now $2.83 billion. Tell us about this guidance raise, and ...

Article found on: www.valuewalk.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up